Low Pretreatment Acoustic Radiation Force Impulse Imaging (ARFI) Values Predict Sustained Virological Response in Antiviral Hepatitis C Virus (HCV) Therapy.
BACKGROUND Non-invasive procedures such as acoustic radiation force impulse imaging (ARFI) shear-wave elastography are currently used for the assessment of liver fibrosis. In the course of chronic hepatitis C, significant liver fibrosis or cirrhosis develops in approximately 25% of patients, which is a negative predictor of antiviral treatment response. Cirrhosis can be prevented by successful virus elimination. In this prospective study, a pretreatment ARFI cutoff value of 1.5 m/s was evaluated in relation to sustained virological response to anti-HCV therapy. MATERIAL AND METHODS In 23 patients with chronic hepatitis C, liver stiffness was examined with ARFI at defined times before and under antiviral triple therapy (peginterferon, ribavirin in combination with a first-generation protease inhibitor, and telaprevir or boceprevir). Patients were stratified into 2 groups based on pretreatment ARFI values (<1.5 m/s and ≥1.5 m/s) for the assessment of virological response. RESULTS The liver stiffness at baseline for all patients was 1.57±0.79 m/s (ARFI median ± standard deviation; margin: 0.81 m/s to 3.45 m/s). At week 4 of triple therapy, patients with low pretreatment ARFI values had higher rates of HCV-RNA negativity (69% vs. 43%), reflecting an early rapid virological response (eRVR). Sustained virological response (SVR) was found in 75% (12/16) of patients with an ARFI value <1.5 m/s and only 57% (4/7) of patients with ARFI value ≥1.5 m/s. CONCLUSIONS Patients with chronic hepatitis C and pretreatment ARFI <1.5 m/s showed earlier virus elimination and better response to treatment.
Medical Department 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Steffen
S
Zopf
Medical Department 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Lara
L
Rösch
Department of Internal Medicine 2, Thüringen Kliniken "Georgius Agricola, Saalfeld, Germany.
Peter C
PC
Konturek
Medical Department 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Ruediger S
RS
Goertz
Medical Department 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Markus F
MF
Neurath
Medical Department 1, University of Erlangen-Nuremberg, Erlangen, Germany.
Deike
D
Strobel
BMC Gastroenterol. 2010 Sep 09;10:103
20828377
World J Hepatol. 2015 Mar 27;7(3):616-27
25848486
Ann Hepatol. 2013 Nov-Dec;12(6):935-41
24114824
Clin Gastroenterol Hepatol. 2015 Apr;13(4):772-9.e1-3
25528010
Science. 1988 Jun 3;240(4857):1285-93
3287615
J Hepatol. 2012 Aug;57(2):281-7
22521355
World J Gastroenterol. 2014 Feb 7;20(5):1289-97
24574802
J Med Virol. 2014 Feb;86(2):241-7
24338811
Liver Int. 2013 Sep;33(8):1138-47
23859217
Mol Med Rep. 2015 Jun;11(6):4174-82
25651500
J Hepatol. 2014 Aug;61(2):373-95
24818984
Eur Radiol. 2013 Nov;23 (11):3040-53
23801420
Med Sci Monit. 2014 Oct 24;20:2027-35
25342166
Am Fam Physician. 2003 Nov 1;68(9):1831-3
14620604
World J Gastroenterol. 2014 Jul 28;20(28):9528-33
25071348
Ultraschall Med. 2010 Apr;31(2):151-5
20306380
Liver Int. 2013 Feb;33 Suppl 1:23-9
23286842
Curr Gastroenterol Rep. 2014 Feb;16(2):372
24452634
Ultraschall Med. 2013 Jun;34(3):238-53
23605169
World J Hepatol. 2016 Jan 28;8(3):139-47
26839638
J Hepatol. 2010 Jun;52(6):846-53
20385422
J Ultrasound Med. 2015 May;34(5):813-21
25911714
Ultraschall Med. 2013 Apr;34(2):169-84
23558397
J Viral Hepat. 2012 Feb;19(2):e212-9
22239521
Curr Med Imaging Rev. 2011 Nov 1;7(4):328-339
22545033
Liver Int. 2012 Feb;32 Suppl 1:39-43
22212570
J Gastrointestin Liver Dis. 2012 Dec;21(4):367-73
23256119
Ultrasound Med Biol. 2015 Jan;41(1):7-14
25308941
Ultraschall Med. 2012 Aug;33(4):380-5
22723037
Hepatology. 2010 Mar;51(3):828-35
20063276
Antiviral Res. 2015 Apr;116:45-7
25660111